SEC Charges California-Based Bio-Rad Laboratories With FCPA Violations
The Securities and Exchange Commission today charged a clinical diagnostic and life science research company based in California with violating the Foreign Corrupt Practices Act (FCPA) when its subsidiaries made improper payments to foreign officials in Russia, Vietnam, and Thailand in order to win business. An SEC investigation found that …